Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Have the Stock Bulls Really Sealed the Short-Term Crack in the Dam?

Stocks again made a new intraday 2020 high yesterday, but the bulls were stopped just a point shy of the 3395 mark. Has yesterday’s increase invalidated our reasons to be cautious and take profits off the table? In other words, can we expect the bulls to push t...

The Crazy Ones - The Explorers

https://skrr.ca/ 2020 has seen incredible work done in Saskatchewan by Taiga Gold, MAS Gold, SSR Mining and SKRR Exploration. Well, we are just getting started. SKRR is going to start drilling the Leland Gold project in the Trans Hudson Corridor within two weeks. A...

Buzz on the Bullboards: Whose stocks sizzle during summer holidays?

As we get through the summer holiday season, the typically calmer market environment presents a prime opportunity for investors to evaluate their portfolios and consider new investments. The TSX continues to offer a variety of promising stocks, particularly in energ...

A Topical Solution for Chronic Pain

Pain impedes the life of millions around the world, and the market for topical creams to treat this pain is growing at an accelerated rate as people choose to treat pain directly vs ingesting pain killers. Some analysts, such as those at Allied Market Research, project that ...

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...

The Fed Meets the S&P 500 Bull

Yesterday's Fed statement drove stock lower, but did the overnight slide tick all the boxes so far – that's the question to ask. And why exactly did the market get so disappointed with the FOMC moves? I'll answer these questions in today's analysis, and lay out the prospects f...

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

Managed IT Services As A Money Saving Mechanism

Successful business owners realize the importance of reducing operating costs without affecting their company’s overall performance. Saving time and money is always a fundamental business goal, and it is more important than ever in small and midsize companies...

BoC’s Double Rate Cut: Is it a benefit for Canadians

The Bank of Canada (BoC) has implemented a 50-basis-point interest rate cut. This is in responds to a weakening labor market and a 5-year bond yield drop to 2.8%. With unemployment at 6.8%—its highest since 2017 (excluding pandemic years)—the move aims to stimulate the ec...

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...
1 2 3 4 5 6 7 8 9 10 ...